Leading Drugmaker Highlights Concerning Situation

GlaxoSmithKline Pakistan's financial performance has been impaired by a challenging business environment, according to the company's senior executive. In an interview with Bloomberg, Chairman and CEO M. Salman Burney said that medicine price controls, ongoing conflict in the northwest of the country and the weakening rupee were major concerns.

To read the full article, please choose one of the following options: